Literature DB >> 15762201

Immediate and midterm complications of sclerotherapy: report of a prospective multicenter registry of 12,173 sclerotherapy sessions.

Jean-Jérôme Guex1, François-André Allaert, Jean-Luc Gillet, Franck Chleir.   

Abstract

BACKGROUND: Growing interest in sclerotherapy has emphasized the need for complete knowledge of all aspects of this method.
OBJECTIVE: To precisely delineate the actual incidence of immediate and delayed untoward events of daily sclerotherapy.
METHODS: A multicenter prospective registry was established in 22 phlebology clinics to report their activity and complications.
RESULTS: During the study period, 12,173 sessions of sclerotherapy were carried out, 5,434 with liquid, 6,395 with foam, and 344 using both. Four thousand eighty-eight (33.9%) sessions were carried out with ultrasound guidance. Forty-nine incidents or accidents (0.4%) occurred, of which 12 were with liquid and 37 with foam. These were reported during the time of the study and an additional 1-month follow-up. Most numerous were 20 cases of visual disturbances (in 19 cases, foam or air block was used); all resolved shortly, without any after-effects. A femoral vein thrombosis was the only severe adverse event in this study.
CONCLUSIONS: This study demonstrates that sclerotherapy is a safe technique.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15762201     DOI: 10.1111/j.1524-4725.2005.31030

Source DB:  PubMed          Journal:  Dermatol Surg        ISSN: 1076-0512            Impact factor:   3.398


  18 in total

Review 1.  [Sclerotherapy for varicosities].

Authors:  F Pannier; E Rabe
Journal:  Hautarzt       Date:  2006-01       Impact factor: 0.751

2.  Compression sclerotherapy for primary valvular insufficiency -from liquid to foam-.

Authors:  Takashi Yamaki
Journal:  Ann Vasc Dis       Date:  2010-07-21

Review 3.  [Guidelines for sclerotherapy of varicose veins : S2k guideline of the German Society of Phlebology (DGP) in cooperation with the following professional associations: DDG, DGA, DDG, BVP. German Version].

Authors:  E Rabe; F X Breu; I Flessenkämper; H Gerlach; S Guggenbichler; B Kahle; R Murena; S Reich-Schupke; T Schwarz; M Stücker; E Valesky; S Werth; F Pannier
Journal:  Hautarzt       Date:  2021-01       Impact factor: 0.751

Review 4.  Visual loss following sclerotherapy for varicose veins.

Authors:  James Chiung Yoong Leong; Nicholas Robert Johnston
Journal:  BMJ Case Rep       Date:  2011-01-25

5.  Venous ulcers: new options in treatment: minimally invasive vein surgery.

Authors:  Honesto Poblete; Steven Elias
Journal:  J Am Col Certif Wound Spec       Date:  2009-05-01

6.  Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.

Authors:  T M Leslie-Mazwi; Laura L Avery; John R Sims
Journal:  Neurocrit Care       Date:  2009-03-17       Impact factor: 3.210

7.  Treatment of varicose veins.

Authors:  Raha Nael; Suman Rathbun
Journal:  Curr Treat Options Cardiovasc Med       Date:  2009-04

8.  Intra-arterial air thrombogenesis after cerebral air embolism complicating lower extremity sclerotherapy.

Authors:  T M Leslie-Mazwi; Laura L Avery; John R Sims
Journal:  Neurocrit Care       Date:  2009-03-11       Impact factor: 3.210

Review 9.  Polidocanol for endovenous microfoam sclerosant therapy.

Authors:  David M Eckmann
Journal:  Expert Opin Investig Drugs       Date:  2009-12       Impact factor: 6.206

10.  Detrimental influences of intraluminally-administered sclerotic agents on surrounding tissues and peripheral nerves: an experimental study.

Authors:  Masahide Fujiki; Masakazu Kurita; Mine Ozaki; Hayato Kawakami; Nobuyuki Kaji; Akihiko Takushima; Kiyonori Harii
Journal:  J Plast Surg Hand Surg       Date:  2012-06-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.